These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16489021)

  • 1. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
    Blyth K; Vaillant F; Hanlon L; Mackay N; Bell M; Jenkins A; Neil JC; Cameron ER
    Cancer Res; 2006 Feb; 66(4):2195-201. PubMed ID: 16489021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
    Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
    Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
    Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
    Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
    Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
    Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
    Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic down-regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-Myc.
    Benanti JA; Wang ML; Myers HE; Robinson KL; Grandori C; Galloway DA
    Mol Cancer Res; 2007 Nov; 5(11):1181-9. PubMed ID: 17982115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.
    Hay J; Gilroy K; Huser C; Kilbey A; Mcdonald A; MacCallum A; Holroyd A; Cameron E; Neil JC
    J Cell Biochem; 2019 Oct; 120(10):18332-18345. PubMed ID: 31257681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic instability and apoptosis are frequent in p53 deficient young mice.
    Fukasawa K; Wiener F; Vande Woude GF; Mai S
    Oncogene; 1997 Sep; 15(11):1295-302. PubMed ID: 9315097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
    Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF
    Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
    Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
    Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene.
    Cameron ER; Morton J; Johnston CJ; Irvine J; Bell M; Onions DE; Neil JC; Campbell M; Blyth K
    Cell Death Differ; 2000 Jan; 7(1):80-8. PubMed ID: 10713723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
    Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
    Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
    Pamidi A; Cardoso R; Hakem A; Matysiak-Zablocki E; Poonepalli A; Tamblyn L; Perez-Ordonez B; Hande MP; Sanchez O; Hakem R
    Cancer Res; 2007 Sep; 67(18):8527-35. PubMed ID: 17875692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUL7 is a novel antiapoptotic oncogene.
    Kim SS; Shago M; Kaustov L; Boutros PC; Clendening JW; Sheng Y; Trentin GA; Barsyte-Lovejoy D; Mao DY; Kay R; Jurisica I; Arrowsmith CH; Penn LZ
    Cancer Res; 2007 Oct; 67(20):9616-22. PubMed ID: 17942889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.